Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colaren and Zoledronic Acid for Secondary Osteoporosis in Men
NCT03930992Phase 3Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Apr 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Colaren in secondary osteoporosis, sponsored by Universidad de Guadalajara. Started Apr 2019; status: completed.
02
Drugs
Colaren
03
Conditions
secondary osteoporosis
Beyond the preview
Go deeper on NCT03930992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03930992.